Home / Drug shortages / Activated Charcoal Oral Suspension

Activated Charcoal Oral Suspension — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Activated Charcoal Oral Suspension (oral suspension) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on 05/15/2026.

Shortage Details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-0521-25
Dosage Form
Oral Suspension
Presentation
Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)
Initial Posting
05/15/2026
Revised Date

FDA data resources